Finafta (benzocaine, glycerin) is filed as Standardized Chemical Allergen [EPC]. The sections below restate public label fields stored for this profile.
Uses For temporary relief of pain associated with canker sores
Warnings Do not exceed recommended dosage Methemoglobinemia warning: Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in the blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: pale, gray, or blue colored skin (cyanosis) headache rapid heart rate shortness of breath dizziness or lightheadedness fatigue or lack of energy Allergy alert do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine, or other "caine" anesthetics. Do not use t his product for more than 7 days unless directed by a dentist or doctor. If sore mouth symptoms do not improve in 7 days; if irritation, pain, or redness persists or worsens; or if swelling, rash or fever develops, see your dentist or doctor promptly.
Purpose Oral Anesthetic Oral Demulcen
Directions •adults and children over 12 years of age apply to the affected area, mouth, gums or mucous membrane with the applicator provided, up to 4 times daily or as directed by a dentist or doctor. Remain in place at least 1 minute and then spit out. Do not rinse mouth after each use • Children between 2 and 12 years of age: consult a doctor •children under 12 years of age should be supervised in the use of the product •do not use in children under 2 years of age.
According to its FDA label, Finafta (benzocaine, glycerin) is approved for: Uses For temporary relief of pain associated with canker sores For medical advice, please talk to your prescriber or pharmacist.
Finafta (benzocaine, glycerin) belongs to the Standardized Chemical Allergen [EPC] class of medications.
The FDA label lists Finafta (benzocaine, glycerin) as: topical route. Available strengths and packaging vary by manufacturer.
Our ingest of the FDA label for Finafta (benzocaine, glycerin) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Finafta (benzocaine, glycerin) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Finafta (benzocaine, glycerin) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA label lists Efficient Laboratories Inc. as a labeler/manufacturer of Finafta (benzocaine, glycerin). Multiple firms may market generics of the same molecule.
Loading full data from Know Your Drugs Institute…